Global Bone Morphogenetic Protein (BMP) 2 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bone Morphogenetic Protein (BMP) 2 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Bone Morphogenetic Protein (BMP) 2 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bone Morphogenetic Protein (BMP) 2 market is projected to reach US$ 675.7 million in 2034, increasing from US$ 498.1 million in 2022, with the CAGR of 4.4% during the period of 2024 to 2034. Demand from Spinal Fusion and Trauma Surgery are the major drivers for the industry.
According to types, the most proportion of the Bone Morphogenetic Protein (BMP) 2 is Sponge, taking almost 99% sales share of global market in 2020. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used for Spinal Fusion and the proportion is about 66% in 2020. Global market of BMP 2 is extremely intensive. Medtronic, Jiuyuan Gene Engineering and Cellumed are the only 3 companies supplying this product. Furthermore, among these companies, Medtronic takes almost 95% share of global market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bone Morphogenetic Protein (BMP) 2 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Medtronic
Jiuyuan Gene Engineering
Cellumed
Segment by Type
Sponge
Gel
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive Surgery
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bone Morphogenetic Protein (BMP) 2 market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Bone Morphogenetic Protein (BMP) 2 introduction, etc. Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Bone Morphogenetic Protein (BMP) 2 market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Bone Morphogenetic Protein (BMP) 2 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bone Morphogenetic Protein (BMP) 2 market is projected to reach US$ 675.7 million in 2034, increasing from US$ 498.1 million in 2022, with the CAGR of 4.4% during the period of 2024 to 2034. Demand from Spinal Fusion and Trauma Surgery are the major drivers for the industry.
According to types, the most proportion of the Bone Morphogenetic Protein (BMP) 2 is Sponge, taking almost 99% sales share of global market in 2020. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used for Spinal Fusion and the proportion is about 66% in 2020. Global market of BMP 2 is extremely intensive. Medtronic, Jiuyuan Gene Engineering and Cellumed are the only 3 companies supplying this product. Furthermore, among these companies, Medtronic takes almost 95% share of global market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bone Morphogenetic Protein (BMP) 2 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Medtronic
Jiuyuan Gene Engineering
Cellumed
Segment by Type
Sponge
Gel
Segment by Application
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive Surgery
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bone Morphogenetic Protein (BMP) 2 market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Bone Morphogenetic Protein (BMP) 2 introduction, etc. Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Bone Morphogenetic Protein (BMP) 2 market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.